Disseminated MAC occurs primarily in patients with severe immune deficiency, such as those with advanced HIV infection, hematologic malignancy, or a history of immunosuppressive therapy, such as anti-tumor necrosis factor-α (TNF-α) therapy (Karakousis, 2009; Winthrop et al., 2009). The gene discussed is TNF; the disease is HIV infectious disease.